Valuation: IRADIMED CORPORATION

Market Cap 1.05B 921M 866M 790M 1.48B 101B 1.48B 10.39B 4.01B 51.48B 3.96B 3.87B 166B P/E 2026 *
42.9x
P/E 2027 * 37.1x
Enterprise Value 1.05B 921M 866M 790M 1.48B 101B 1.48B 10.39B 4.01B 51.48B 3.96B 3.87B 166B EV / Sales 2026 *
11.6x
EV / Sales 2027 * 10.4x
Free-Float
64.83%
Yield 2026 *
-
Yield 2027 * -
1 day+2.95%
1 week+4.08%
Current month-0.71%
1 month-1.62%
3 months-6.46%
6 months-13.54%
Current year-11.83%
1 week 81.51
Extreme 81.51
86.19
1 month 81.4
Extreme 81.405
89.13
Current year 76.95
Extreme 76.95
107.9
1 year 67.84
Extreme 67.8421
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
3/9/26 Sell

Director

-1,419 0.0111%
4/6/26 Sell

Director

-3,000 0.0235%
1/6/26 Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
+3.04%+4.08%+21.30%+97.35% 1.05B
-0.21%+0.01%-30.79%-1.01% 12.52B
+7.15%+9.16%+19.63%+17.90% 4.2B
+0.81%+4.36%-42.38%-58.48% 1.24B
-1.81%+1.08%-41.80%-42.99% 1.1B
+0.86%+7.79%-35.12% - 1.04B
+1.91%+4.97% - - 997M
+0.20%+1.22%+35.82%+107.59% 510M
-0.16%-2.98%+30.32% - 310M
+0.46%-8.23%-71.07%+318.35% 225M
Average +1.22%+0.96%-12.68%+62.67% 2.32B
Weighted average by Cap. +1.40%+2.01%-18.19%+8.24%

Financials

2026 *2027 *
Net sales 91.2M 79.7M 74.91M 68.36M 128M 8.72B 128M 899M 347M 4.45B 342M 335M 14.35B 101M 88.26M 82.96M 75.7M 142M 9.66B 142M 996M 384M 4.93B 379M 371M 15.9B
Net income 24.65M 21.54M 20.25M 18.48M 34.68M 2.36B 34.68M 243M 93.76M 1.2B 92.57M 90.54M 3.88B 28.45M 24.86M 23.37M 21.32M 40.02M 2.72B 40.03M 280M 108M 1.39B 107M 104M 4.48B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
23/09/26 USD 85.77 +4.01% 62,738
21/09/26 USD 82.46 +0.41% 120,118
18/09/26 USD 82.12 -0.75% 211,442
17/09/26 USD 82.74 +0.19% 91,004
16/09/26 USD 82.58 +0.21% 115,966
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
82.46USD
Average target price
118.00USD
Spread / Average Target
+43.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!